BMP2 and osteoporosis: Emerging gene therapy strategies for osteoporosis have shown promise in preclinical studies, where engineered cells overexpressing BMP-2 or type I collagen successfully increased bone mass and accelerated fracture healing in osteoporotic animal models, including rats and sheep.229–231 Beyond conventional DNA-based gene therapy, cmRNA approaches are also being explored for their therapeutic potential in osteoporosis.